Close

Novavax (NVAX) Tops Q1 EPS by 1c

May 8, 2017 4:14 PM EDT

Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $5.680 million versus the consensus estimate of $6.17 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings